We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.7B
AUM Growth
+$40.6M
Cap. Flow
+$34.9M
Cap. Flow %
2.05%
Top 10 Hldgs %
99.78%
Holding
13
New
1
Increased
1
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$38.7M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$3.69M
2
SER icon
Serina Therapeutics
SER
+$116K

Sector Composition

Rank Sector Weight
1 Consumer Staples 36.93%
2 Healthcare 30.27%
3 Industrials 23.14%
4 Miscellaneous 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.7B
$629M 36.93%
16,397,992
-102,864
-0.6% -$3.69M
AXON
2
Axon Enterprise
AXON
$38.4B
$394M 23.14%
693,504
STAA icon
3
STAAR Surgical
STAA
$1.13B
$347M 20.37%
15,019,491
+1,500,000
+11% +$38.7M
IWM icon
4
iShares Russell 2000 ETF
IWM
$77.2B
$117M 6.87%
474,920
IMDX
5
Insight Molecular Diagnostics
IMDX
$125M
$85.6M 5.03%
11,410,100
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$266M
$82.8M 4.86%
49,560,992
UAL icon
7
CALL
United Airlines
UAL
$34.6B
$16.8M 0.99%
150,000
AAL icon
8
CALL
American Airlines Group
AAL
$8.5B
$12.6M 0.74%
820,000
LUV icon
9
CALL
Southwest Airlines
LUV
$19B
$7.56M 0.44%
183,000
GIL icon
10
CALL
Gildan
GIL
$8.7B
$7.04M 0.41%
+112,750
New +$6.7M
DAL icon
11
CALL
Delta Air Lines
DAL
$51.4B
$3.64M 0.21%
52,500
SER icon
12
Serina Therapeutics
SER
$58.2M
$104K 0.01%
54,484
-28,711
-35% -$116K
HBI
13
CALL
DELISTED
Hanesbrands
HBI
-1,127,500
Closed -$1.83M

Similar funds

Broadwood Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Broadwood Capital held 13 positions worth $1.7B, up 2.4% from $1.66B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q4 2025 filing shows 1 new, 1 increased, 2 reduced and 1 closed positions. The largest sale was Monster Beverage, an estimated $3.69M.

By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Broadwood Capital added most to STAAR Surgical in Q4 2025, an estimated $38.7M increase.
  • Broadwood Capital's biggest Q4 2025 reduction was Monster Beverage, cutting an estimated $3.69M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.7B portfolio in Q4 2025.
  • Broadwood Capital opened 1 new position and closed 1 in Q4 2025.
  • Broadwood Capital's portfolio value rose 2.4% quarter-over-quarter to $1.7B.

Based on Broadwood Capital's 13F filing for Q4 2025, filed 17 Feb 2026.